8.4% Sodium Bicarbonate Locks in Intestinal Failure
NCT05813535 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2026-05-28
Summary
We plan to include children with intestinal failure, a condition where the gut is not functioning properly, leading these children to need central venous catheters (line that goes through the skin into the blood stream) for nutritional support and hydration. Such patients have a very high risk for catheter infection. The study will include placing an agent (sodium bicarbonate) into the central catheter when the catheter is not in use. This is referred to as a lock. The lock would be used daily and removed when patients start their nutritional support and hydration through the catheter.
Conditions
- Intestinal Failure
- CRBSI - Catheter Related Bloodstream Infection
Interventions
- DRUG
-
Sodium bicarb lock
8.4% sodium bicarb locks when off venous nutrition
Sponsors & Collaborators
-
Riad Rahhal
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-01
- Primary Completion
- 2025-03-01
- Completion
- 2025-03-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection
NCT00304356 ·Status: COMPLETED ·Phase: PHASE3
-
High-fat Diet (HFD) and Small Intestinal Microbiome
NCT07019142 ·Status: COMPLETED ·Phase: NA
-
Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis
NCT00304889 ·Status: COMPLETED
-
Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea
NCT01868373 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Freeze-dried, Capsulized FMT for RCDI
NCT02399618 ·Status: UNKNOWN ·Phase: PHASE1
-
Fecal Transplant for Pediatric Patients Who Have Recurrent C-diff Infection
NCT02134392 ·Status: UNKNOWN ·Phase: PHASE1
-
Stool Transplant to Control Treatment-related Diarrhea
NCT04883762 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Eluxadoline Bile Acid Malabsorption (BAM) Study
NCT03441581 ·Status: COMPLETED ·Phase: PHASE4
-
Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury
NCT02355938 ·Status: TERMINATED ·Phase: PHASE4
-
Intracolonic Vancomycin Therapy in Severe C. Diff Colitis
NCT01346059 ·Status: TERMINATED ·Phase: NA
-
The Clostridioides Difficile Trial of REC-3964
NCT06536465 ·Status: TERMINATED ·Phase: PHASE2
-
Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections
NCT05606159 ·Status: WITHDRAWN ·Phase: NA
-
Rescue FMT with Bezlotoxumab for Recurrent C. Difficile Infection
NCT06669936 ·Status: COMPLETED
-
Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Infection
NCT03834038 ·Status: COMPLETED ·Phase: NA
-
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
NCT03353506 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection
NCT04885946 ·Status: UNKNOWN ·Phase: NA
-
Fecal Microbiota Transplant for Primary CDI
NCT03795233 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Transplantation of Fecal Microbiota for Clostridium Difficile Infection
NCT01958463 ·Status: UNKNOWN ·Phase: PHASE3
-
Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe
NCT01630096 ·Status: UNKNOWN ·Phase: PHASE4
-
Ursodeoxycholic Acid in C. Difficile Infection
NCT05526807 ·Status: TERMINATED ·Phase: NA
-
A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea
NCT00382304 ·Status: COMPLETED ·Phase: PHASE2
-
Harnessing the Healthy Gut Microbiota to Cure Patients With Recurrent C. Difficile Infection
NCT01372943 ·Status: TERMINATED ·Phase: NA
-
Intestinal Lavage for the Treatment of Severe C. Difficile Infections
NCT02466698 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Response of Clostridium Difficile Infection to Metronidazole Therapy
NCT00304369 ·Status: COMPLETED
-
Networks of Bacterium-Metabolite Interactions in the Small Intestine
NCT04978077 ·Status: TERMINATED ·Phase: NA